Newly passed House bill could close orphan drug loophole ...
文章推薦指數: 80 %
The FDA can grant seven years of market exclusivity to a drug if it's intended to treat a condition affecting fewer than 200,000 patients in the U.S., ... Skiptomaincontent Pharma NewlypassedHousebillcouldcloseorphan
延伸文章資訊
- 1The Enduring Role of Orphan Drug Exclusivity for Biologics ...
Orphan Drugs receive a 7-year period of exclusivity from product approval - effective on the date...
- 2Orphan drug - Wikipedia
An orphan drug is a pharmaceutical agent developed to treat medical conditions which, because the...
- 3Orphan Drugs in the United States - IQVIA
- 4ORPHAN DRUGS IN THE UNITED STATES: - National ...
development in the rare disease space by offering grants, tax credits for clinical trial costs, w...
- 5Orphan Drug Exclusivity Keeps Biosimilars Off the Market ...
Orphan Drug Exclusivity Keeps Biosimilars Off the Market, Study Says ... Investigators found that...